RICERCA ITALIANA     

FIRB simili:

• 1 - Meccanismi neuro/endocrini centrali e periferici coinvolti nel controllo della efficienza produttiva e riproduttiva e nella risposta all'ambiente negli animali di interesse zootecnico
• 2 - Riconoscimento molecolare e funzionalità cellulare
• 3 - Molecole innovative ad attività antiflogistica ed antitumorale prodotte con metodologie chimiche avanzate
• 4 - Interazioni funzionali tra proteine delle sinapsi: fisiopatologia e potenziali indicazioni terapeutiche
• 5 - Meccanismi di regolazione dello sviluppo del sistema nervoso e del differenziamento neurale (PRONEURO)
• 6 - Modelli di dipendenza: correlati molecolari e funzionali.
• 7 - Geni murini, fenotipi e malattie umane - MousePHD
• 8 - Ectoenzimi leucocitari e loro coinvolgimento nella patogenesi, diagnosi e terapia di selezionate patologie umane
• 9 - Sviluppo di Tecnologie Avanzate per lo Studio della Proteomica Differenziale del Segnale (Segnalo-Proteomica)
• 10 - Modelli transgenici per malattie ad eziologia complessa

Classificazione scientifico-disciplinare

• Area scientifico disciplinare: Scienze biologiche
  • FARMACOLOGIA
• Area scientifico disciplinare: Scienze mediche
  • PATOLOGIA GENERALE
  • ENDOCRINOLOGIA

Classificazione brevettuale

• HUMAN NECESSITIES
  • AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • ANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
  • MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES (bringing into special physical form A61J [N: mechanical aspects]; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; compounds per se C01, C07, C08, C12N; soap compositions C11D; micro-organisms per se C12N) [C0203]

Classificazione geografica

• Regione: Lombardia

Bibliografia

1)Bercu BB, Walker RF (Eds.) 1996. Growth hormone-releasing peptides. In: Growth hormone secretagogues. Springer, New York pp. 85-102.
2)Ducy P, Amling M, Takeda S, Priemel M, Schilling AF, Beil FT, Shen J, Vinson C, Rueger JM, Karsenty G. Leptin inhibits bone formation through a hypothalamic relay: a central control of bone mass. Cell 2000; 100:197-200.
3)Westvik J. Radiological features in generalized lipodystrophy. Acta Paediatrica 1996; Supplement 413:44-51.
4)Sobhani I, Bado A, Vissuzaine C, Buyse M, Kermorgant S,Laigneau JP, Attroub S, Lehy T, Henin D, Mignon M, Lewin MJ. Leptin secretion and leptin receptor in human stomach. Gut 2000; 47:178-183.
5)Bisballe I, Eriksen EF, Melsen F, Mosekilde L, Sorensen OH, Hessov I. Osteopenia and osteomalacia after gastrectomy: interrelations between biochemical markers of bone remodeling, vitamin D metabolites, and bone histomorphometry. Gut 1991; 32:1303-1307.
6)Rumenapf G, Schwille PO, Erben RG, Schreiber M, Fries W, Schmiedl A, Hohenberger W. Osteopenia followng total gastrectomy in the rat-state of mineral metabolism and bone histomorphometry. Eur. Surg. Res. 1997; 29:209-221.
7)Brzozowski T, Konturek PC, Konturek SJ, Paydo R, Duda A, Pierzchalski P, Bielanski W, Hahn EG. Leptin in gastroprotection induced by cholecystokinin or by a meal. Role of vagal and sensory nerves and nitric oxide. Eur. J. Pharmacol. 1999; 374:263-276.
8)Konturek PC, Brzozowski T, Sulekova Z, Brzozowska I, Duda A, Meixner H, Hahn EG, Konturek SJ. Role of leptin in ulcer healing. Eur. J. Pharmacol. 2001; 414:87-97.
9)Konturek PC, Brzozowski T, Sulekova Z, Meixner H, Hahn EG, Konturek SJ. Enhanced expression of leptin following acute gastric injury in rat. J. Physiol. Pharmacol. 1999; 50:587-595.
10)Bowers CY, Momany FA, Raynolds GA, Chang D, Hong A, Chang K. Structure-activity relationships of a synthetic pentapeptide that specifically releases growth hormone in vitro. Endocrinology 1984; 106:663-667.
11)Chen C, Wu D, Clarks U. Signal transduction systems employed by synthetic GH-releasing peptides in somatotrophs. J. Endocrinol. 1996; 148:381-386.
12)Howard AD, Feighner SD, Cully DF,Arena JP, Liberator PA, Rosenblum CI, Hamelin M, Hreniuk DL, Palyha OC, Anderson J, Paress PS, Diaz C, Chou M, Liu KK, McKee KK, Pong SS, Chaung LY, Elbrecht A, Dashkevicz M, Heavens R, Rigby M, Sirinathsinghji DJ, Dean DC, Melillo DG, Van der Ploeg LH. A receptor in pituary and hypothalamus that functions in growth hormone release. Science 1996; 273:974-977.
13)Papotti M, Ghe C, Cassoni P, Catapano F, Deghenghi R, Ghigo E, Muccioli G. Growth hormone secretagogue binding sites in peripheral human tissues. J. Clin. Endocrinol. Metab. 2000; 85:3803-3807.
14)Locatelli V, Rossoni G, Schweiger F, Torsello A, De Gennaro Colonna V, Bernareggi M, Deghenghi R, Muller EE, Berti F. Growth hormone-independent cardioprotective effects of hexarelin in the rat. Endocrinology 1999; 140:4024-4031.
15)Torsello A, Locatelli V, Melis MR, Succu S, Spano MS, Deghenghi R, Muller EE, Argiolas A. Orexigenic effects of hexarelin and its analogs in the rat hypothalamus: indication for multiple growth hormone secretagogue receptor subtypes. Neuroendocrinology 2000; 72:327-332.
16)Melis MR, Succu S, Spano MS, Deghenghi R, Argiolas A. EP 91073 prevents EP 80661-induced penile erection: new evidence for the existence of specific EP peptide receptors mediating penile erection. Neuropharmacology 2001; 41:254-262.
17)Melis MR, Succu S, Spano MS, Torsello A, Locatelli V, Muller EE, Deghenghi R, Argiolas A. Penile erection induced by EP 80661 and other hexarelin peptide analogues: involvement of paraventricular nitric oxide. Eur. J. Pharmacol. 2001; 411:305-310.
18)Kojima M, Hosoda H, Date Y, Nakazato M, Matsuo H, Kangawa K. Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature 1999; 402:656-660.
19)Arvat E, Di Vito L, Broglio F, Papotti M, Muccioli G, Dieguez C, Casanueva FF, Deghenghi R, Camanni F, Ghigo E. Preliminary evidence that Ghrelin, the natural GH secretagogue (GHS)-receptor ligand, strongly stimulates GH secretion in humans. J. Endocrinol. Invest. 2000; 23:493-495.
20)Mori K, Yoshimoto A, Takaya K, Hosoda K, Ariyasu H, Yahata K, Mukoyama M, Sugawara A, Hosoda H, Kojima M, Kangawa K, Nakao K. Kidney produces a novel acylated peptide, ghrelin. FEBS Letters 2000; 486:213-216.
21)Inui A. Ghrelin: an orexygenic and somatotrophic signal from the stomach. Nature reviews 2001; 2:551-560.
22)Levi A, Eldridge JD, Paterson B. Molecular cloning of a gene sequence regulated by Nerve Growth Factor. Science 1985; 229:393-395.
23)Possenti R, Eldridge JD, Paterson BM, Grasso A, Levi A. A protein induced by NGF in PC12 cells is stored in secretory vesicles and released through the regulated pathway. EMBO J. 1989; 8:2217-2223.
24)Ferri GL, Levi A, Possenti R. A novel neuroendocrine gene product: selective VGF8a gene expression and immunolocalization of VGF protein in endocrine and neuronal population. Molec. Brain Research. 1992; 13:139-143.
25)Snyder SE, Pintar JE, Salton SRJ. Developmental expression of VGF mRNA in the prenatal and postnatal rat. J. Comp. Neurol. 1998; 394:64-90.
26)Possenti R, Rinaldi AM, Ferri GL, Borboni P, Trani E, Levi A. Expression, processing and secretion of the neuroendocrine VGF peptides by INS-1 cells. Endocrinology 1999; 140: 3727-3735.
27)Salton RJS, Ferri GL, , Hahm S, Snyder SE, Wilson AJ, Possenti R, Levi A. VGF: a novel role for this neuronal and neuroendocrine polypeptide in the regulation of energy balance. Front. Neuroendocrin. 2000; 21:199-219.

Parole Chiave

ghrelina azioni extraendocrine; VGF azioni biologiche; leptina metabolismo osseo,attività gastriche; regolazione alimentare,obesità; regolazione metabolica,proteine disaccoppianti; integrazione neuroendocrina